Although Finacea is a lower concentration than azelaic acid cream, Dr.
Thieroff-Ekerdt stated that some patients in preapproval trials described burning, stinging, tingling, and/or itching when they applied Finacea.
Unlike some topical medications whose effectiveness levels off after eight weeks, in a medical trial, rosacea sufferers using Finacea experienced a continuous decline in symptoms throughout 12 weeks of treatment.
Finacea is indicated for topical treatment of inflammatory papules and pustules of mild to moderate rosacea.
Finacea is for dermatologic use only, and not for ophthalmic, oral, or intravaginal use.
The introduction of FINACEA brings to this important market an exciting new therapy for the treatment of rosacea," said Bill Humphries, Allergan's Vice President U.
FINACEA, the first new therapeutic class option to be approved for the treatment of rosacea in more than a decade, will be launched in March 2003 at the Winter American Academy of Dermatology (AAD) meeting in San Francisco.
FINACEA contains azelaic acid, a naturally occurring saturated dicarboxylic acid.
FINACEA is for dermatological use only, and not for ophthalmic, oral, or intravaginal use.